LPGAT1 blocking peptide

LPGAT1 Blocking Peptide

Gene Names

LPGAT1; NET8; FAM34A; FAM34A1

Applications

Blocking/Control

Purity

The purity is >90%,tested by HPLC and MS.

Synonyms

LPGAT1; LPGAT1 Blocking Peptide; Acyl CoA:lysophosphatidylglycerol acyltransferase 1; Acyl-CoA:lysophosphatidylglycerol acyltransferase 1; FAM34A; FAM34A1; Family with sequence similarity 34 member A; KIAA0205; LGAT1_HUMAN; Lpgat1; lysophosphatidylglycerol acyltransferase 1; NET8; LPGAT1 blocking peptide

Ordering
Cat. Num. AAA9628171 For Research Use Only!

Purity/Purification

The purity is >90%,tested by HPLC and MS.

Form/Format

Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.

Applicable Applications for LPGAT1 blocking peptide

Blocking/Control

Notes

For phospho antibody, we provide phospho peptide (0.5mg) and non-phospho peptide (0.5mg)

Preparation and Storage

Maintain refrigerated at 2-8 degree C for up to 6 months. For long term storage store at -20 degree C.

Related Product Information for LPGAT1 blocking peptide

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (immunoblot) and immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or immunostaining performed with the neutralized antibody.

NCBI and Uniprot Product Information

NCBI GI #

1002924686

NCBI GeneID

9926

NCBI Accession #

NP_001307737.1

NCBI GenBank Nucleotide #

NM_001320808.1

UniProt Accession #

Q92604; Q53YL2

Molecular Weight

43,089 Da

NCBI Official Full Name

acyl-CoA:lysophosphatidylglycerol acyltransferase 1

NCBI Official Synonym Full Names

lysophosphatidylglycerol acyltransferase 1

NCBI Official Symbol

LPGAT1

NCBI Official Synonym Symbols

NET8; FAM34A; FAM34A1

NCBI Protein Information

acyl-CoA:lysophosphatidylglycerol acyltransferase 1

UniProt Protein Name

Acyl-CoA:lysophosphatidylglycerol acyltransferase 1

Protein Family

Acyl-CoA:lysophosphatidylglycerol acyltransferase

UniProt Gene Name

LPGAT1

UniProt Synonym Gene Names

FAM34A; KIAA0205

UniProt Entry Name

LGAT1_HUMAN

NCBI Description

This gene encodes a member of the lysophospholipid acyltransferase family. The encoded protein catalyzes the reacylation of lysophosphatidylglycerol to phosphatidylglycerol, a membrane phospholipid that is an important precursor for the synthesis of cardiolipin. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]

Uniprot Description

LPGAT1: Lysophoshatidylglycerol (LPG) specific acyltransferase that recognizes various acyl-CoAs and LPGs as substrates but demonstrates a clear preference for long chain saturated fatty acyl-CoAs and oleoyl-CoA as acyl donors. Prefers oleoyl-LPG over palmitoyl-LPG as an acyl receptor and oleoyl-CoA over lauroyl-CoA as an acyl donor. Belongs to the 1-acyl-sn-glycerol-3-phosphate acyltransferase family.

Protein type: Membrane protein, integral; Transferase; EC 2.3.1.-; Membrane protein, multi-pass

Chromosomal Location of Human Ortholog: 1q32

Cellular Component: endoplasmic reticulum membrane; membrane; cytoplasm; integral to membrane

Molecular Function: transferase activity, transferring acyl groups

Biological Process: phospholipid metabolic process; glycerophospholipid biosynthetic process

Research Articles on LPGAT1

1. LPGAT1 is a novel gene that influences BMI in Native Americans.

Similar Products

LPGAT1 Antibody

Host: n/a

Reactivity: n/a

Apps: n/a

Product Notes

The LPGAT1 lpgat1 (Catalog #AAA9628171) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. AAA Biotech's LPGAT1 can be used in a range of immunoassay formats including, but not limited to, Blocking/Control. Researchers should empirically determine the suitability of the LPGAT1 lpgat1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "LPGAT1, Blocking Peptide" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.

Precautions

All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.

Disclaimer

Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.

Loading...

LPGAT1 blocking peptide